Redeye: Acconeer - Strong Module Demand Could Not Be Processed
Redeye maintains its view of Acconeer, following the company’s Q4 report. We reiterate our valuation.
Read more and download the Research Update.
Follow companies at Redeye to receive the latest equity research within Life Science and Technology.
This is a press release from Redeye - Research Powered Investment Banking. www.redeye.se/